An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1479-1483

  Voglino, G ^a   Castello, S ^a   Silengo, L ^c   Stefanuto, G ^c   Friard, O ^c   Ferrara, G ^b   Fessia, L ^a  

^a Ospedale Sant'Anna   (Italy)

^b Laboratory of Immunogenetics   (Italy)

^c NONE

Author keywords

Breast cancer; Exon skipping; Mutational analysis; P53; RT PCR

Indexed keywords

ARTICLE; BREAST CANCER; EXON; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; EXONS; FEMALE; GENE DELETION; GENES, P53; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA;

EID: 0030767226     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00136-6     Document Type: Article

References (14)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutation in human cancer. Science 1991, 253, 49-53.
2. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993, 262, 1980-1981.
3. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathway. Nature 1993, 352, 849-852.
4. Marx J. How p53 suppresses cell growth. Science 1993, 262, 1644-1645.
5. Zambetti GP, Levine AJ. A comparison of biological activities of wild-type and mutant p53. FASEB J 1993, 7, 855-865.
6. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993, 85, 200-206.
7. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL. Prognostic significance of TP53 alteration in breast carcinoma. Br J Cancer 1993, 68, 540-548.
8. Tsuda H, Iwaya K, Fukutomi T, Hirohashi S. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinoma of high histological grade. Jpn J Cancer Res 1993, 84, 394-401.
9. Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommers SS. Mutation detection by highly sensitive method indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 1996, 93, 1093-1096.
10. Beroud C, Verdier F, Soussi T. p53 gene mutation: software and database. Nucleic Acids Res 1996, 24, 147-150.
11. Hartmann A, Blaszyk H, McGovern RM, et al. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 1995, 10, 681-688.
12. Hall SL, Padgett RA. Requirement of U12 snRNA for in vivo splicing of minor class of eukariotic nuclear pre-mRNA introns. Science 1996, 271, 1716-1718.
13. Cariello NF, Douglas GR, Soussi T. Databases and software for the analysis of mutation in human p53 gene, the human hprt gene and lacZ gene in transgenic rodents. Nucleic Acids Res 1996, 24, 119-120.
14. Wieringa B, Hofer E, Weissmann C. A minimal intron length but no specific internal sequence is required for splicing the large rabbit β-giobin intron. Cell 1984, 37, 915-925.